Here's an interesting study on LSD, MDMA, psilocybin, and other psychedelic substances, which (yet again) has failed to show a link with depression, anxiety, and suicidal thoughts or behaviours. In fact, the researcher behind this study found that use of psychedelics was linked to a decrease in inpatient psychiatric treatment.
These findings add to a growing body of evidence indicating that psychedelic drugs may not only be safe but actually therapeutic when it comes to mental health.
Of course, I am in no way advocating that we all just go out and start using these regularly, but I wanted to share this study with you as another example of how far government propaganda has gone in brainwashing their citizens into believing these are 100% bad substances. Anyone who thinks for themselves will know that's just not true.
"The research suggests that psychiatrists shouldn't be prejudiced against psychedelic drugs and that if they have patients who use these drugs, it's not necessarily bad for them," said the study's investigator. "Clinicians should know that it's possible to prescribe psychedelic drugs right now, today, although there could be some paperwork involved," she added.
For the study, the investigators used the annual National Survey on Drug Use and Health (NSDUH), which collects data on substance use and mental health from a random sample that is representative of the US civilian noninstitutionalized population. They pooled data from respondents aged 18 years and older from survey years 2008 to 2011.
The sample consisted of 135,095 respondents, of whom 19,299 (13.6% weighted) reported lifetime use of a psychedelic substance ― including LSD, psilocybin, mescaline, or peyote. These are all classic serotonergic psychedelics whose main mechanism of action is at the 5-HT2A receptor. The researchers examined 11 self-reported indicators of past-year mental health problems, including depression, anxiety disorders, and suicide thoughts, plans, and attempts.
The study found that psychedelic users were more likely than nonusers to be younger, male, white, unmarried, to carry out risky activities, and to have used other drugs. They were also more likely to report a depressive episode before age 18 years. It is possible, said the researcher, that childhood depression prompts some people to try psychedelic drugs.
Lifetime psychedelic use was not associated with any of the indicators of mental health problems, but instead, their use was associated with about a 20% lower likelihood of past-year inpatient mental health treatment.
Looking at individual psychedelic drugs, the study showed statistically significant associations between psilocybin use and lower likelihood of past-year serious psychological distress, inpatient mental health treatment, and psychiatric medication prescription (aOR, 0.9; P = .007). This actually follows the results of another study I covered just over 3 years ago (click HERE for that one). Also, past-year use of LSD was associated with about a 20% lower likelihood of serious psychological distress.
However, mescaline or peyote use was associated with a greater likelihood of a major depressive episode in the past year (although the statistical significance was very weak and that the effect size was small, and their use was not associated with a official/physician diagnosis of depression).
The researchers behind this study also debunked a number of myths surrounding psychedelics, including the so-called "flashbacks" (a full-on myth), addiction potential (negligible risk, and actually used and investigated as medicine to overcome addictions to alcohol and cocaine), lack of medical use (lots of documented medicinal uses), and prevalence of use (just as many use now as they did back in the 1960s).
Click HERE to subscribe to Know Guff.
Source: Psychedelics not linked to mental health problems or suicidal behavior: A population study
- Medicinal Uses for "Magic" Mushrooms
- Could Alzheimer's Patients Benefit from Marijuana?
- Marijuana for Alzheimer's Prevention?
- Marijuana Benefits HDL Cholesterol, Insulin Levels, and Waist Circumference
- Marijuana Extract Provides Relief for Multiple Sclerosis
- Run From the Cure (Medical Marijuana Documentary)